OOIR: Observatory of International Research

Papers

(The H4-Index of Intensive Care Medicine is 53. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Variation in intensive care unit beds capacity in China from 2007 to 2021	582
Obituary and tribute to Professor J. Randall Curtis (Randy)	203
The effects of pantoprazole vs. placebo on 1-year outcomes, resource use and employment status in ICU patients at risk for gastrointestinal bleeding: a secondary analysis of the SUP-ICU trial	187
Effect of proning and recruitment on physio-anatomical variables in COVID-19 pneumonia	180
Time course of physiological variables during inter-hospital helicopter transport of ventilated COVID-19 patients	177
Basic ultrasound skill for intensivists: future scope for expansion of the recommendations of the European Society of Intensive Care Medicine	161
Full enteral nutrition should be avoided among patients with high vasopressor dose and low flow state	150
Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis	145
Weaning strategy in patients at low-to-medium risk of extubation failure	142
Workplace equity for clinicians with a disability: why it matters for all	141
Major adverse kidney events as an endpoint in acute kidney injury trials: is it time for a RE-MAKE?	140
Personalized oxygen targets are needed for extracorporeal membrane oxygenation	133
Preventing stress ulcer bleeding	128
No ventilation, no ARDS: insights from four-dimensional computed tomography as dynamic imaging	115
Quantifying benefit and harm of extracorporeal life support in cardiogenic shock complicating acute myocardial infarction	112
Close collaboration between pathologists and intensivists to understand (not just) coronavirus disease	110
The certainty of parental love vs. the uncertainty of a “best” decision	106
Optimal oxygen and mean arterial blood pressure targets after cardiac arrest	102
Pitfalls in the use of microcirculation as a resuscitation goal	100
Correction to: Noninvasive respiratory support in intensive care medicine	96
ICU venous thromboembolism prophylaxis: revisiting external validity, vulnerable subgroups, and diagnostic standards, with future directions. Authors' reply	91
Norepinephrine dose and concentration reporting: a closer look at the fine print	89
Staircase strategy, tier-three therapies, and effects on outcome in traumatic brain injured patients: the Triple-T TBI study	86
Dose of norepinephrine: the devil is in the details	84
Persistent signs of poisoning after massive drug ingestion: move the ultrasound probe to the stomach	83

Mental health sequelae in survivors of cardiogenic shock complicating myocardial infarction. A population-based cohort study	82
Comparing intravascular and surface cooling methods: a critical look at outcomes for out-of-hospital cardiac arrest patients—author's reply	81
A double plea for dyspnea as the next great cause of all ICU professions and for caution about the dyspnea-breathlessness equivalence	79
Beyond inflammation: the role of metabolic dysregulation in sepsis diagnosis and treatment	79
Severe Pneumocystis jirovecii pneumonia: time to reassess our practices	77
Sequencing interventions in ARDS: the critical role of timing and order in standardized management	77
Greenery and outdoor facilities to improve the wellbeing of critically ill patients, their families and caregivers: things to consider	76
Age and associated outcomes among patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory failure: analysis of the Extracorporeal Life Support Organization registry	75
Correction: Expanding the role of PoCUS in tailoring diuretic strategies for congestion management in critical care	74
18F-fluorodeoxyglucose positron emission tomography/computed tomography differentiates between pneumonia and atelectasis in a mechanically ventilated patient	71
Frailty in intensive care medicine must be measured, interpreted and taken into account!	70
Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury	69
Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions	65
Lung-protective sedation: moving toward a new paradigm of precision sedation	65
SHAP model explainability in ECMO–PAL mortality prediction: a critical analysis	63
Nicotine patches in patients on mechanical ventilation for severe COVID-19: a randomized, double-blind, placebo-controlled, multicentre trial	63
Long-term mortality and health-related quality of life of lower versus higher oxygenation targets in ICU patients with severe hypoxaemia	62
Hemodynamic and neurological presentations of invasive meningococcal disease in adults: a nationwide study across 100+ French ICUs	62
Serum sickness: a mimic of septic shock	61
Measuring patient’s effort on the ventilator	60
Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis	58
Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial	57
Anesthetic drugs for rapid sequence intubation: ketamine, but what dose?	55
Using the helmet	55
Status epilepticus in the ICU	54
Frailty, Outcomes, Recovery and Care Steps of Critically Ill Patients (FORECAST): a prospective, multi-centre, cohort study	54
Reassessing open lung ventilation in ARDS: an updated meta-analysis of the 2023 ESICM guidelines highlights risks of routine use and supports individualized strategies	54
Left ventricular diastolic dysfunction is prevalent but not associated with mortality in patients with septic shock	54
Should we move beyond the concept of fluid responsiveness?	53
B-ICONIC vs. Reality: The Feasibility Gap in Neuro-Ultrasound Recommendations and Achievability. Authors’ reply	53